The Hartford Healthcare Fund Class R4 (HGHSX)
| Fund Assets | 788.79M |
| Expense Ratio | 1.31% |
| Min. Investment | $0.00 |
| Turnover | 40.00% |
| Dividend (ttm) | 1.90 |
| Dividend Yield | 5.17% |
| Dividend Growth | n/a |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 36.97 |
| YTD Return | -6.12% |
| 1-Year Return | -18.25% |
| 5-Year Return | 0.83% |
| 52-Week Low | 35.40 |
| 52-Week High | 47.56 |
| Beta (5Y) | n/a |
| Holdings | 91 |
| Inception Date | Dec 22, 2006 |
About HGHSX
The Hartford Mutual Funds, Inc.: Hartford Healthcare Fund; Class R4 Shares is an open-end mutual fund that targets long-term capital appreciation by investing primarily in the global health care sector. Its strategy is to allocate at least 80% of assets to equity securities of companies connected to health care industries, including pharmaceuticals, biotechnology, medical products, services, and health care delivery. The fund is sub-advised by Wellington Management Company LLP, leveraging in-depth research to identify high-conviction investment opportunities and capitalize on demographic shifts, globalization, and innovation trends within the health care market. It typically holds 85–100 securities and focuses heavily on U.S.-based firms, with a modest allocation to foreign equities. The R4 share class is designed to be accessible, featuring no minimum investment requirement for standard taxable accounts and an expense ratio around 1.3%. Notable for its annual dividend distribution and a competitive yield, the fund provides investors with targeted exposure to a vital and evolving sector that is integral to global economies and public well-being.
Performance
HGHSX had a total return of -18.25% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.39%.
Top 10 Holdings
46.52% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.89% |
| UnitedHealth Group Incorporated | UNH | 6.80% |
| Boston Scientific Corporation | BSX | 4.90% |
| Intuitive Surgical, Inc. | ISRG | 4.17% |
| Merck & Co., Inc. | MRK | 3.69% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.34% |
| Johnson & Johnson | JNJ | 2.91% |
| Cencora, Inc. | COR | 2.89% |
| Gilead Sciences, Inc. | GILD | 2.47% |
| Thermo Fisher Scientific Inc. | TMO | 2.46% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
| Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
| Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
| Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
| Dec 10, 2019 | $2.36232 | Dec 11, 2019 |
| Dec 17, 2018 | $2.4841 | Dec 18, 2018 |